ENGLEWOOD, Colo., April 3, 2017 /PRNewswire/ -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the divestiture of Primsol®, an oral antibiotic solution for urinary tract...
April 03, 2017 at 05:27PM
http://ift.tt/2ot01RI
from
http://ift.tt/2ot01RI
No comments:
Post a Comment